Inhibition of lymphokine-activated killer cell generation by blocking factors in sera of patients with head and neck cancer

A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone

Steven A. Rosenberg, Michael T. Lotze, Linda Muul et al. · New England Journal of Medicine · 1987 · 2.8K citations

Pharmacy, Immunology, Oncology +14

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Elizabeth A. Grimm, A Mazumder, H Z Zhang et al. · The Journal of Experimental Medicine · 1982 · 2.2K citations · Full text

Life Sciences, Immunology, Oncology +15

Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer

William H. West, Kurt W. Tauer, John R. Yannelli et al. · New England Journal of Medicine · 1987 · 1.2K citations

Medicine, Immunology, Oncology +16

Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

Rudolf H. Zubler, Ghislaine Lange, P H Lambert et al. · PubMed · 1976 · 723 citations

Life Sciences, Biochemistry, Immunology +13

Detection of Immune Complexes in Unheated Sera by a Modified 125I-C1q Binding Test

Rudolf H. Zubler, Ghislaine Lange, P H Lambert et al. · The Journal of Immunology · 1976 · 513 citations

Life Sciences, Biochemistry, Immunology +15